bf/NASDAQ:LXRX_icon.jpeg

NASDAQ:LXRX

Lexicon Pharmaceuticals, Inc.

  • Stock

0.72

−0.86%

−0.34

USD last updated 13/08 01:59:42

Last Close

1.06

12/08 22:30

Market Cap

589.23M

Beta: 1.33

Volume Today

4.08M

Avg: 593.73K

PE Ratio

−3.21

PFCF: −3.75

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II ...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -0.50.511.522018-11-012020-04-272022-02-282023-08-032024-11-06

    Revenue (Estimate*)

    50M100M150M200M250M300M2018-11-012020-04-272022-02-282023-08-032024-11-06

    *Estimate based on analyst consensus